Goldman Sachs Put 220 PGR 16.08.2.../ DE000GG681P2 /
2024-06-25 10:49:21 AM | Chg.-0.11 | Bid12:57:34 PM | Ask12:57:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.21EUR | -8.33% | 1.17 Bid Size: 3,000 |
1.37 Ask Size: 1,000 |
Progressive Corporat... | 220.00 USD | 2024-08-16 | Put |
GlobeNewswire
1:00 PM
Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren
GlobeNewswire
12:15 PM
Fujifilm Launches 128-Slice Computed Tomography System, FCT iStream, with Vision Modeling Iterative ...
GlobeNewswire
12:05 PM
Lulus Expands Footwear Offering By Welcoming Vans Into All-New “Lulus Loves” Capsule
GlobeNewswire
06-24
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporat...
GlobeNewswire
06-24
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
06-24
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
06-24
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
06-13
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
06-12
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
06-12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
06-11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
06-11
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire
06-11
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire
06-10
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
06-10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
06-07
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-07
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...